Loading…
BioVie Inc. is projected to rise to $3.58 by 2027, a +58% move from its current price of $2.27. BIVI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.17 | $2.27 | $2.38 | +0.07% |
| Jul 14 | $2.13 | $2.27 | $2.43 | +0.15% |
| Jul 15 | $2.09 | $2.28 | $2.47 | +0.22% |
| Jul 16 | $2.07 | $2.28 | $2.50 | +0.30% |
| Jul 17 | $2.05 | $2.28 | $2.54 | +0.37% |
| Jul 18 | $2.03 | $2.28 | $2.56 | +0.45% |
| Jul 19 | $2.01 | $2.28 | $2.59 | +0.52% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.01 | $2.28 | $2.59 | +0.52% |
| Week 2 | $1.92 | $2.29 | $2.74 | +1.05% |
| Week 3 | $1.85 | $2.31 | $2.87 | +1.58% |
| Week 4 | $1.80 | $2.32 | $2.98 | +2.11% |
| Week 5 | $1.76 | $2.33 | $3.09 | +2.65% |
| Week 6 | $1.72 | $2.34 | $3.19 | +3.18% |
| Week 7 | $1.69 | $2.35 | $3.29 | +3.72% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BioVie Inc. is a clinical-stage biopharmaceutical company focused on developing drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in Phase 2 for the treatment of ascites due to chronic liver cirrhosis, and NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program.
The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
BioVie Inc. trades under the symbol BIVI and sits in the Healthcare sector. Its current price is $2.27 with a market cap of $17.12M, and it ranks 4,926th by market capitalization.
A major floor 49.9% below — a decisive break under it would weaken the trend.
The nearest floor, 37.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 25.0% above — clearing it would confirm fresh momentum.
Key BIVI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BIVI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.19 | Buy | $2.19 | Buy |
| MA 10 | $2.10 | Buy | $2.11 | Buy |
| MA 20 | $1.94 | Buy | $1.98 | Buy |
| MA 50 | $1.69 | Buy | $1.76 | Buy |
| MA 100 | $1.54 | Buy | $1.71 | Buy |
| MA 200 | $1.53 | Buy | $3.65 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.89 | Neutral |
| Stoch RSI (14) | 79.99 | Neutral |
| CCI (20) | 140.56 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 17.01 | Buy |
| Bollinger %B (20,2) | 0.92 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.15 | Buy |
| Awesome (5,34) | 0.40 | Buy |
| Ultimate (7,14,28) | 69.66 | Neutral |
| Momentum (10) | 0.49 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 2.27 | Buy |
| ADX (14) | 24.24 | Buy |
| ATR (14) | 0.08 | Info |
The stock’s near-term setup shows bullish sentiment with RSI(14) at 70. The stock trades above the SMA50 of $1.69 and the SMA200 of $1.53, suggesting a constructive trend. Key levels to watch are support at $1.42 and resistance at $2.27.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.06 | $2.27 | $3.88 | 0% | Neutral | |
| $2.65 | $3.58 | $5.21 | +58% | Bullish | |
| $3.01 | $4.29 | $6.62 | +89% | Bullish | |
| $2.77 | $4.12 | $6.65 | +82% | Bullish | |
| $2.51 | $3.90 | $6.52 | +72% | Bullish | |
| $2.72 | $4.38 | $7.58 | +93% | Bullish | |
| $2.77 | $4.63 | $8.23 | +104% | Bullish | |
| $3.47 | $5.99 | $10.94 | +164% | Bullish | |
| $3.92 | $6.99 | $13.05 | +208% | Bullish | |
| $3.69 | $6.81 | $13.00 | +200% | Bullish | |
| $4.64 | $9.97 | $20.78 | +339% | Bullish | |
| $7.90 | $17.57 | $40.40 | +674% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.06 | $2.27 | $2.82 | +0.00% |
| August 2026 | $2.05 | $2.46 | $3.08 | +8.50% |
| September 2026 | $1.99 | $2.43 | $3.10 | -1.35% |
| October 2026 | $1.96 | $2.42 | $3.13 | -0.39% |
| November 2026 | $2.16 | $2.69 | $3.52 | +10.97% |
| December 2026 | $2.33 | $2.92 | $3.88 | +8.87% |
Click any year to see its month-by-month BIVI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BIVI is projected to trade between $1.06 and $3.88, averaging $2.27 — a potential gain of 0% from today's $2.27. A consolidation phase looks the most probable path here.
BioVie Inc.'s 2027 outlook centres on $3.58, within a $2.65 to $5.21 range. That is up +58% on the projected 2026 average. That marks a +58% change versus current levels. Momentum favours further upside here.
By 2028, BIVI could reach as high as $6.62, with a base case around $4.29 and support toward $3.01 — roughly +89% from $2.27. Buyers look set to stay in control over this stretch.
Expect BIVI to range from $2.77 to $6.65 through 2029. The $4.12 average target implies a +82% move from current prices. That is -4% versus the projected 2028 average. Momentum favours further upside here.
The BIVI price prediction for 2030 points to an average of $3.90 (low $2.51, high $6.52) — a potential gain of +72% on today's $2.27. Buyers look set to stay in control over this stretch.
In 2031, BIVI is projected to trade between $2.72 and $7.58, averaging $4.38 — a potential gain of +93% from today's $2.27. That is up +13% on the projected 2030 average. Momentum favours further upside here.
BioVie Inc.'s 2032 outlook centres on $4.63, within a $2.77 to $8.23 range. That is up +6% on the projected 2031 average. That marks a +104% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, BIVI could reach as high as $10.94, with a base case around $5.99 and support toward $3.47 — roughly +164% from $2.27. Momentum favours further upside here.
Expect BIVI to range from $3.92 to $13.05 through 2034. The $6.99 average target implies a +208% move from current prices. That is up +17% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The BIVI price prediction for 2035 points to an average of $6.81 (low $3.69, high $13.00) — a potential gain of +200% on today's $2.27. Momentum favours further upside here.
In 2040, BIVI is projected to trade between $4.64 and $20.78, averaging $9.97 — a potential gain of +339% from today's $2.27. That is up +46% on the projected 2035 average. Buyers look set to stay in control over this stretch.
BioVie Inc.'s 2050 outlook centres on $17.57, within a $7.90 to $40.40 range. That is up +76% on the projected 2040 average. That marks a +674% change versus current levels. Momentum favours further upside here.
Investing $1,000 in BIVI today (≈ 440.528634 BIVI) could be worth
$7,738.6
+$6,738.6 (+674%) by 2050 · US Dollar
Based on the average projected BIVI price of $17.57 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BIVIwould be worth at today's price.
$1,000 invested in BIVI on Jul 10, 2025 (≈ 132.100393 BIVI) would be worth
$299.87
-$700.13 (-70.0%) today · 0.30× · US Dollar
Based on a BIVI entry price of $7.57 vs. today's $2.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.95 | $1,164.1 | +16.4% |
| 1 month ago | $1.63 | $1,392.64 | +39.3% |
| 3 months ago | $1.35 | $1,681.48 | +68.1% |
| 6 months ago | $1.26 | $1,801.59 | +80.2% |
| 1 year ago | $7.57 | $299.87 | -70.0% |
| All time (5.0y) ago | $1,584 | $1.43 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BIVI forecast.
Our base-case forecast reaches $4.50 around 2032.
Implied market cap at $4.50: $33.94M
The multi-year forecast paints a rising path for BioVie. In 2026 the avg price is $2.27 with a min of $1.06 and a max of $3.89 (ROI 0, sentiment NEUTRAL). By 2027 the avg rises to $3.58 (ROI 57.6, sentiment BULLISH) and expands further to an avg of $4.29 in 2028 (ROI 89.2) and $4.12 in 2029 (ROI 81.6).
The forecast continues higher with an avg of $3.89 in 2030 (ROI 71.5) and $4.39 in 2031 (ROI 93.5). By 2032 the avg is $4.62 (ROI 103.6), and by 2033 the avg is $5.99 (ROI 163.9). The uptrend extends to 2034 with an avg of $7.01 (ROI 208.7) and 2035 with an avg of $6.80 (ROI 199.6).
The path accelerates to an avg of $9.98 by 2040 (ROI 339.7) and to $17.57 by 2050 (ROI 674.2). Across these years the sentiment remains BULLISH.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $3.89, with a min of $2.51 and a max of $6.52; ROI is 71.5% and sentiment is BULLISH.
Forecasts show bullish sentiment from 2027 onward with positive ROIs: 57.6% in 2027, 89.2% in 2028, 81.6% in 2029, 71.5% in 2030, and continuing to higher levels (e.g., 93.5% in 2031, 103.6% in 2032, 163.9% in 2033, 208.7% in 2034, 199.6% in 2035, 339.7% in 2040, and 674.2% in 2050). These are estimates and not guaranteed.
Yes, the 2033 max forecast is $10.93, with an avg of $5.99 and a min of $3.47; ROI is 163.9% and sentiment is BULLISH.
Current price is $2.27 and market cap is $17.12M.
The 30-day picture is bullish with RSI(14) at 70. The stock trades above SMA50 ($1.69) and SMA200 ($1.53), with support at $1.42 and resistance at $2.27. The 30-day range spans from $1.66 to $3.11.
BioVie Inc. Community Discussion
0Share your BioVie Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.